SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-026442
Filing Date
2021-04-13
Accepted
2021-04-13 16:35:16
Documents
2
Period of Report
2021-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1594
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4046
  Complete submission text file 0001209191-21-026442.txt   7030
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O ASPEN TECHNOLOGY, INC. 20 CROSBY DRIVE BEDFORD MA 01730
Business Address
Keresty Georgia (Reporting) CIK: 0001773532 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 21823418